Q2 2025 Management View CEO Adam S. Grossman opened by stating that "ADMA's second quarter 2025 performance underscores the strength of our operating model, the success of our strategic execution and ...

Baker Mayfield addressed the NFL’s 2025 smelling salts ban with sarcasm and hinted at a surprising new game day energy boost.

The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million ...

A Rankin County teenager’s life-changing medication is being denied approval by the U.S. Food and Drug Administration, leaving him and many others with rare diseases unsure of their futures.

Ginger may play a positive role in blood sugar management. Get an expert’s take on the herb’s potential health benefits for people with diabetes, including a reduced HbA1C and more flavorful food ...

In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the ...

MAX BioPharma and Revilico Collaboration LOS ANGELES, CA / ACCESS Newswire / August 6, 2025 / Today MAX BioPharma, Inc. ( and Revilico, Inc. ( announced their collaboration in studying the mechanisms ...

Jazz Pharmaceuticals bet $1 billion on the commercial potential of a first-in-class oral imipridone for recurrent H3 K27M-mutant diffuse glioma.

Aurinia Pharmaceuticals Inc. achieved record Lupkynis sales of $66.6M in Q2 while managing cash flow. Click for insights on ...

The company's revenue (GAAP) reached $21.2 million, up from $15.3 million in Q2 2024, outpacing the analyst consensus of $20.45 million (GAAP). Earnings per share (EPS, GAAP) were $(0.38), also better ...

During the NFL Networks' Tuesday training camp coverage, a former Iowa football legend interrupted to share his view on the new ban on smelling salts.

You may have heard an influencer say you’re infected with worms or parasites and then been promised a “cleanse cure.” Our ...